246 related articles for article (PubMed ID: 15289859)
1. Cyclin D1 overexpression is not a specific grouping marker, but may collaborate with CDC37 in myeloma cells.
Katayama Y; Sakai A; Okikawa Y; Oue N; Asaoku H; Sasaki A; Imanaka F; Tsujimoto T; Takimoto Y; Masuda R; Nakaju N; Otsuki T; Yasui W; Kimura A
Int J Oncol; 2004 Sep; 25(3):579-95. PubMed ID: 15289859
[TBL] [Abstract][Full Text] [Related]
2. Frequency and distribution of trisomy 11 in multiple myeloma patients: relation with overexpression of CCND1 and t(11;14).
Guglielmelli T; Giugliano E; Cappia S; Papotti M; Saglio G
Cancer Genet Cytogenet; 2007 Feb; 173(1):51-6. PubMed ID: 17284370
[TBL] [Abstract][Full Text] [Related]
3. Identification of cyclin D1 mRNA overexpression in B-cell neoplasias by real-time reverse transcription-PCR of microdissected paraffin sections.
Specht K; Kremer M; Müller U; Dirnhofer S; Rosemann M; Höfler H; Quintanilla-Martinez L; Fend F
Clin Cancer Res; 2002 Sep; 8(9):2902-11. PubMed ID: 12231535
[TBL] [Abstract][Full Text] [Related]
4. Ectopic cyclin D1 overexpression increases chemosensitivity but not cell proliferation in multiple myeloma.
Kuroda Y; Sakai A; Tsuyama N; Katayama Y; Munemasa S; Asaoku H; Okikawa Y; Nakaju N; Mizuno M; Ogawa K; Nishisaka T; Matsui H; Tanaka H; Kimura A
Int J Oncol; 2008 Dec; 33(6):1201-13. PubMed ID: 19020753
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical analysis identifies two cyclin D1+ subsets of plasma cell myeloma, each associated with favorable survival.
Cook JR; Hsi ED; Worley S; Tubbs RR; Hussein M
Am J Clin Pathol; 2006 Apr; 125(4):615-24. PubMed ID: 16627271
[TBL] [Abstract][Full Text] [Related]
6. The (11;14)(q13;q32) translocation in multiple myeloma. A morphologic and immunohistochemical study.
Hoyer JD; Hanson CA; Fonseca R; Greipp PR; Dewald GW; Kurtin PJ
Am J Clin Pathol; 2000 Jun; 113(6):831-7. PubMed ID: 10874884
[TBL] [Abstract][Full Text] [Related]
7. [Invasive ductal carcinoma of the breast: study of the number of copies of the CCND1 gene and chromosome 11 using fluorescence in situ hybridization (FISH) in comparison with expression of cyclin D1 protein and estrogen receptors (ER alpha) with immunohistochemical detection].
Mrhalová M; Kodet R; Strnad P
Cas Lek Cesk; 2002 Nov; 141(22):708-14. PubMed ID: 12532908
[TBL] [Abstract][Full Text] [Related]
8. Complex analysis of cyclin D1 expression in mantle cell lymphoma: two cyclin D1-negative cases detected.
Stefancikova L; Moulis M; Fabian P; Falkova I; Vasova I; Kren L; Macak J; Smardova J
J Clin Pathol; 2009 Oct; 62(10):948-50. PubMed ID: 19783727
[TBL] [Abstract][Full Text] [Related]
9. Cyclin D1 positive multiple myeloma: predominance of the short, 3'UTR-deficient transcript is associated with high cyclin D1 mRNA levels in cases with t(11;14) translocation, but does not correlate with proliferation rate or genomic deletions.
Slotta-Huspenina J; Koch I; Richter M; Bink K; Kremer M; Specht K; Krugmann J; Quintanilla-Martinez L; Fend F
Leuk Res; 2008 Jan; 32(1):79-88. PubMed ID: 17629555
[TBL] [Abstract][Full Text] [Related]
10. Molecular classification of multiple myeloma: a distinct transcriptional profile characterizes patients expressing CCND1 and negative for 14q32 translocations.
Agnelli L; Bicciato S; Mattioli M; Fabris S; Intini D; Verdelli D; Baldini L; Morabito F; Callea V; Lombardi L; Neri A
J Clin Oncol; 2005 Oct; 23(29):7296-306. PubMed ID: 16129847
[TBL] [Abstract][Full Text] [Related]
11. CCND1 polymorphisms (A870G and C1722G) modulate its protein expression and survival in oral carcinoma.
Sathyan KM; Nalinakumari KR; Abraham T; Kannan S
Oral Oncol; 2008 Jul; 44(7):689-97. PubMed ID: 18061526
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical analysis of cyclin D1 shows deregulated expression in multiple myeloma with the t(11;14).
Pruneri G; Fabris S; Baldini L; Carboni N; Zagano S; Colombi MA; Ciceri G; Lombardi L; Rocchi M; Buffa R; Maiolo AT; Neri A
Am J Pathol; 2000 May; 156(5):1505-13. PubMed ID: 10793062
[TBL] [Abstract][Full Text] [Related]
13. Cyclin D1 gene activation in human myeloma cells is independent of DNA hypomethylation or histone hyperacetylation.
Krieger S; Grunau C; Sabbah M; Sola B
Exp Hematol; 2005 Jun; 33(6):652-9. PubMed ID: 15911089
[TBL] [Abstract][Full Text] [Related]
14. Gene rearrangement and overexpression of PRAD1 in lymphoid malignancy with t(11;14)(q13;q32) translocation.
Seto M; Yamamoto K; Iida S; Akao Y; Utsumi KR; Kubonishi I; Miyoshi I; Ohtsuki T; Yawata Y; Namba M
Oncogene; 1992 Jul; 7(7):1401-6. PubMed ID: 1535701
[TBL] [Abstract][Full Text] [Related]
15. Cyclin D1 overexpression and response to bortezomib treatment in a breast cancer model.
Ishii Y; Pirkmaier A; Alvarez JV; Frank DA; Keselman I; Logothetis D; Mandeli J; O'Connell MJ; Waxman S; Germain D
J Natl Cancer Inst; 2006 Sep; 98(17):1238-47. PubMed ID: 16954476
[TBL] [Abstract][Full Text] [Related]
16. Intranuclear expression of cyclin D1 protein as a useful prognostic marker for mantle cell lymphoma.
Hashimoto Y; Nakamura N; Kuze T; Abe M; Wakasa H
Fukushima J Med Sci; 1997 Dec; 43(2):87-98. PubMed ID: 9640844
[TBL] [Abstract][Full Text] [Related]
17. Chromosomal translocations involving 11q13 contribute to cyclin D1 overexpression in squamous cell carcinoma of the head and neck.
Akervall J; Borg A; Dictor M; Jin C; Jin Y; Tanner M; Isola J; Mertens F; Wennerberg J
Int J Oncol; 2002 Jan; 20(1):45-52. PubMed ID: 11743641
[TBL] [Abstract][Full Text] [Related]
18. Identification of overexpressed genes in frequently gained/amplified chromosome regions in multiple myeloma.
Largo C; Alvarez S; Saez B; Blesa D; Martin-Subero JI; González-García I; Brieva JA; Dopazo J; Siebert R; Calasanz MJ; Cigudosa JC
Haematologica; 2006 Feb; 91(2):184-91. PubMed ID: 16461302
[TBL] [Abstract][Full Text] [Related]
19. Cell cycle analysis and expression of cell cycle regulator genes in myeloma cells overexpressing cyclin D1.
Yata K; Sadahira Y; Otsuki T; Sakaguchi H; Isozaki Y; Uno M; Kurebayashi J; Fujii T; Eda S; Ueki A; Yawata Y; Yamada O; Sugihara T
Br J Haematol; 2001 Sep; 114(3):591-9. PubMed ID: 11552984
[TBL] [Abstract][Full Text] [Related]
20. Cyclin D2, but not cyclin D1, overexpression closely correlates with gastric cancer progression and prognosis.
Takano Y; Kato Y; Masuda M; Ohshima Y; Okayasu I
J Pathol; 1999 Oct; 189(2):194-200. PubMed ID: 10547574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
